Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)
China flag China · Delayed Price · Currency is CNY
50.66
+0.56 (1.12%)
At close: Feb 3, 2026

SHE:301096 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
372.74428.97881.931,2392,013133.62
Trading Asset Securities
17083----
Cash & Short-Term Investments
542.74511.97881.931,2392,013133.62
Cash Growth
17.48%-41.95%-28.81%-38.46%1406.49%-29.23%
Accounts Receivable
918.67744.4532.18254.49124.4163.38
Other Receivables
2.673.164.14.794.14.87
Receivables
921.34747.56536.28259.28128.568.25
Inventory
221.74177.3493.1766.0522.853.62
Prepaid Expenses
---1.83--
Other Current Assets
132.46108.6196.443.9461.233.51
Total Current Assets
1,8181,5451,6081,6102,226239.01
Property, Plant & Equipment
1,7711,8321,7411,075566.63253.46
Long-Term Investments
204.41187.78136.8781.125.776.67
Other Intangible Assets
90.6993.4392.0782.3760.7962.03
Long-Term Accounts Receivable
---1.911.951.86
Long-Term Deferred Tax Assets
34.335.5548.4353.4122.8610.55
Long-Term Deferred Charges
1.151.420.253.9914.4118.25
Other Long-Term Assets
2725.843.1421.626.9247.96
Total Assets
3,9473,7213,6692,9302,925639.79
Accounts Payable
110.3641.82130.25167.0312.643.38
Accrued Expenses
18.0139.973.444.6954.813.68
Short-Term Debt
728.46360.08369.32-5.0119.03
Current Portion of Long-Term Debt
-104.25--220.32-
Current Portion of Leases
66.440.730.388.848.8-
Current Income Taxes Payable
7.30.035.065.736.171.72
Current Unearned Revenue
95.54112.4274.0162.6171.1750.39
Other Current Liabilities
3.88110.14193.771.893.7933.5
Total Current Liabilities
1,030769.38846.19290.7472.69121.69
Long-Term Debt
238.67244--40.44135.22
Long-Term Leases
2.862.920.93-8.14-
Long-Term Unearned Revenue
25.6631.4840.671.45--
Long-Term Deferred Tax Liabilities
---4.320.010.01
Other Long-Term Liabilities
64.2694.0297.17150.9785.8342.71
Total Liabilities
1,3611,142984.97447.45607.1299.63
Common Stock
109.23109.23108.92108.17108.1781.13
Additional Paid-In Capital
2,1072,1072,1272,0612,026185.55
Retained Earnings
419.61413.49498.68313.24183.9873.51
Treasury Stock
-50-50-50---
Comprehensive Income & Other
-0.19-0.14-0.14---
Total Common Equity
2,5852,5792,6842,4832,318340.19
Minority Interest
----0.26-0.14-0.02
Shareholders' Equity
2,5852,5792,6842,4822,318340.17
Total Liabilities & Equity
3,9473,7213,6692,9302,925639.79
Total Debt
1,036711.99370.648.84282.7154.24
Net Cash (Debt)
-493.7-200.02511.291,2301,730-20.62
Net Cash Growth
---58.43%-28.92%--
Net Cash Per Share
-4.79-1.864.7211.3421.34-0.26
Filing Date Shares Outstanding
108.45108.45108.14108.17108.17108.17
Total Common Shares Outstanding
108.45108.45108.14108.17108.1781.13
Working Capital
788.27776.1761.591,3191,753117.31
Book Value Per Share
23.8423.7824.8222.9521.434.19
Tangible Book Value
2,4952,4862,5922,4002,257278.16
Tangible Book Value Per Share
23.0022.9223.9722.1920.873.43
Buildings
-863.44859.97196.19196.14-
Machinery
-1,099629.9642.96319.94108.62
Construction In Progress
-206.66448.82546.21104.08186.61
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.